Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer
Benjamin H. Press1, Tashzna Jones1, Olamide Olawoyin1, Soum D. Lokeshwar1, Syed N. Rahman1, Ghazal Khajir1, Daniel W. Lin2,3, Matthew R. Cooperberg4,5, Stacy Loeb6, Burcu F. Darst7, Yingye Zheng3, Ronald C. Chen8, John S. Witte9, Tyler M. Seibert10,11,12, William J. Catalona13, Michael S. Leapman1, Preston C. Sprenkle1
1Department of Urology, Yale School of Medicine, New Haven, CT, USA
2Department of Urology, University of Washington, Seattle, WA, USA
3Fred Hutchinson Cancer Research Center, Cancer Prevention Program, Public Health Sciences, Seattle, WA, USA
4Department of Urology, University of California-San Francisco, San Francisco, CA, USA
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA
6Departments of Urology and Population Health, New York University Langone Health and Manhattan Veterans Affairs Medical Center, New York, NY, USA
7University of Southern California Center for Genetic Epidemiology, Keck School of Medicine, Los Angeles, CA, USA
8Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, USA
9Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA
10Department of Radiation Medicine and Applied Sciences, University of California-San Diego, La Jolla, CA, USA
11Department of Radiology, University of California, San Diego, La Jolla, CA, USA
12Department of Bioengineering, University of California-San Diego, La Jolla, CA, USA
13Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
European Urology Open Science
Tập 37
113-119
Thông tin tác giả